145 related articles for article (PubMed ID: 15671570)
1. Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.
Vlastos AT; West LA; Atkinson EN; Boiko I; Malpica A; Hong WK; Follen M
Clin Cancer Res; 2005 Jan; 11(1):390-6. PubMed ID: 15671570
[TBL] [Abstract][Full Text] [Related]
2. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.
Boiko IV; Mitchell MF; Hu W; Pandey DK; Mathevet P; Malpica A; Hittelman WN
Clin Cancer Res; 1998 Jun; 4(6):1383-91. PubMed ID: 9626454
[TBL] [Abstract][Full Text] [Related]
4. DNA image cytometric measurement as a surrogate end point biomarker in a phase I trial of alpha-difluoromethylornithine for cervical intraepithelial neoplasia.
Boiko IV; Mitchell MF; Pandey DK; White RA; Hu W; Malpica A; Nishioka K; Boone CW; Atkinson EN; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):849-55. PubMed ID: 9332769
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity, and cost-effectiveness.
Kaufman RH; Adam E; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1997 Oct; 177(4):930-6. PubMed ID: 9369847
[TBL] [Abstract][Full Text] [Related]
6. Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial.
Rahangdale L; Lippmann QK; Garcia K; Budwit D; Smith JS; van Le L
Am J Obstet Gynecol; 2014 Apr; 210(4):314.e1-314.e8. PubMed ID: 24384495
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.
Keefe KA; Schell MJ; Brewer C; McHale M; Brewster W; Chapman JA; Rose GS; McMeeken DS; Lagerberg W; Peng YM; Wilczynski SP; Anton-Culver H; Meyskens FL; Berman ML
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1029-35. PubMed ID: 11588128
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of basing treatment on human papillomavirus and/or cytology results in low-grade cervical lesion triage.
Bjerre P; Silfverdal L; Dillner L; Hagmar B; Edvardsson H; Dillner J; Andersson-Ellström A
Am J Obstet Gynecol; 2008 Jul; 199(1):24.e1-7. PubMed ID: 18295172
[TBL] [Abstract][Full Text] [Related]
9. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.
Lytwyn A; Sellors JW; Mahony JB; Daya D; Chapman W; Ellis N; Roth P; Lorincz AT; Gafni A
CMAJ; 2000 Sep; 163(6):701-7. PubMed ID: 11022584
[TBL] [Abstract][Full Text] [Related]
10. Oral diindolylmethane (DIM): pilot evaluation of a nonsurgical treatment for cervical dysplasia.
Del Priore G; Gudipudi DK; Montemarano N; Restivo AM; Malanowska-Stega J; Arslan AA
Gynecol Oncol; 2010 Mar; 116(3):464-7. PubMed ID: 19939441
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.
Follen M; Atkinson EN; Schottenfeld D; Malpica A; West L; Lippman S; Zou C; Hittelman WN; Lotan R; Hong WK
Clin Cancer Res; 2001 Nov; 7(11):3356-65. PubMed ID: 11705848
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2.
Hillemanns P; Garcia F; Petry KU; Dvorak V; Sadovsky O; Iversen OE; Einstein MH
Am J Obstet Gynecol; 2015 Apr; 212(4):465.e1-7. PubMed ID: 25467012
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
Meyskens FL; Surwit E; Moon TE; Childers JM; Davis JR; Dorr RT; Johnson CS; Alberts DS
J Natl Cancer Inst; 1994 Apr; 86(7):539-43. PubMed ID: 8133537
[TBL] [Abstract][Full Text] [Related]
14. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears.
Shlay JC; Dunn T; Byers T; Barón AE; Douglas JM
Obstet Gynecol; 2000 Sep; 96(3):410-6. PubMed ID: 10960635
[TBL] [Abstract][Full Text] [Related]
15. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
Koeneman MM; Kruse AJ; Kooreman LFS; Zur Hausen A; Hopman AHN; Sep SJS; Van Gorp T; Slangen BFM; van Beekhuizen HJ; van de Sande M; Gerestein CG; Nijman HW; Kruitwagen RFPM
BMC Cancer; 2016 Feb; 16():132. PubMed ID: 26897518
[TBL] [Abstract][Full Text] [Related]
16. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia.
Kaufman RH; Adam E; Icenogle J; Lawson H; Lee N; Reeves KO; Irwin J; Simon T; Press M; Uhler R; Entman C; Reeves WC
Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):87-92. PubMed ID: 9024095
[TBL] [Abstract][Full Text] [Related]
17. Low-dose topical delivery of all-trans retinoic acid for cervical intraepithelial neoplasia II and III.
Ruffin MT; Bailey JM; Normolle DP; Michael CW; Bieniasz ME; Kmak DC; Unger ER; Brenner DE
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2148-52. PubMed ID: 15598773
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with an increased risk of prevalent and incident grade III cervical intraepithelial neoplasia and invasive cervical cancer among women with Papanicolaou tests classified as grades I or II cervical intraepithelial neoplasia.
Petry KU; Böhmer G; Iftner T; Davies P; Brummer O; Kühnle H
Am J Obstet Gynecol; 2002 Jan; 186(1):28-34. PubMed ID: 11810080
[TBL] [Abstract][Full Text] [Related]
19. Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study.
Margolis KL; Carson LF; Setness PA; Stanley MW; Henry-Stanley MJ; Beneke J; Linzie B; McGlennen RC
Arch Fam Med; 1999; 8(5):433-9. PubMed ID: 10500518
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of cervical cancer with folic acid: a phase III Southwest Oncology Group Intergroup study.
Childers JM; Chu J; Voigt LF; Feigl P; Tamimi HK; Franklin EW; Alberts DS; Meyskens FL
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):155-9. PubMed ID: 7742723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
